NINDS Reflects on 2025: Progress, Collaboration, and Commitment in Neuroscience
The National Institute of Neurological Disorders and Stroke (NINDS) reflected on its 2025 activities, highlighting progress, collaboration, and commitment across the neuroscience community. The year included advancements in understanding the brain and nervous system, with efforts to translate discoveries into treatments for neurological disorders. Dr. Walter Koroshetz, former Director, was recognized for his leadership.
The year included advancements in understanding the brain and nervous system, with efforts to translate discoveries into treatments for neurological disorders.
2025 Research Advances
NINDS highlighted its "Top 10 NINDS Research Advances of 2025," showcasing basic, translational, and clinical research. These advances covered various neurological conditions and scientific approaches, contributing to understanding disease causes and introducing new tools and treatments for prevention, diagnosis, and care.
75th Anniversary
The institute marked its 75th anniversary, founded by Congress in 1950. This milestone provided an opportunity to review its role in expanding neuroscience and supporting discoveries. The anniversary celebrations included special events and partnerships, while also focusing on future progress and emerging technologies.
Notable historical advances include early insights into nerve signaling, brain development, deep brain stimulation for movement disorders, clot-removal therapies for stroke, and gene-targeted approaches for rare neurological diseases.
Nonprofit Forum and Partnerships
In 2025, the NINDS Nonprofit Forum convened patient advocates, nonprofit leaders, researchers, and federal partners. The forum emphasized the crucial role of nonprofit organizations and patient communities in shaping research priorities, accelerating translation, and ensuring scientific advances meet patient needs. This collaborative approach aims to align scientific progress with the experiences of individuals living with neurological conditions.
Funding and Strategic Investments
NINDS maintained support for a broad research portfolio throughout 2025, adapting to evolving NIH policies and fiscal realities. NINDS aims to balance stability with innovation, utilizing resources to maximize scientific opportunity and public health benefits.
The institute's funding strategy prioritizes:
- Investigator-initiated research.
- High-quality peer review.
- Translation from discovery to clinical impact.
- Workforce development, with a focus on early-stage investigators.
Future Outlook
The institute acknowledged the dedication and collaboration of its grantees, trainees, research participants, partners, advocates, and staff for their contributions to neuroscience. NINDS expressed gratitude for the community's resilience, independence, and focus, particularly in challenging times, and their continued efforts to advance neurological health.